TIMP2 and kidney cancer: Di Martino et al. [53], recently discussed that utilizing miR-221 inhibitor was able to increase molecular tumor suppressor tissue inhibitor of metalloproteinase 2 (TIMP2) levels thus improving the cell membrane integrity and hence contributes to the inhibition of kidney cancer.